Innervace
New York, US · Founded 2020 · 2 known investors
Biotech
Founders & leadership
NH
Nader HalimExecutive Officer, Director
JL
Jonathan LeffDirector
AS
Althea StillmanExecutive Officer, Director
DG
David GreenwaldDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$10MraisedAug 2022 · 7 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nader HalimExecutive Officer, Director
- Jonathan LeffDirector
- Althea StillmanExecutive Officer, Director
- David GreenwaldDirector
- Offering amount
- $40M
- Amount sold
- $10M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.